Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Moberg Derma reveals plan to list on NASDAQ OMX

This article was originally published in Scrip

Executive Summary

Moberg Derma has dusted off its plans to float on the NASDAQ OMX in Stockholm, albeit with a lower price and fund raising target. The Swedish dermatology-focused pharma company has applied to raise SEK 74 million ($12.3 million) by issuing 2,551,724 shares at SEK 29 each. Last December, the company pulled its planned offering of 3.1 to 3.8 million shares at SEK 37 to SEK 45 each, citing insufficient demand to ensure a successful offering.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012772

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel